REFERENCES
The complete list of references can be found at www.expertconsult.com.
REFERENCES
1. Magdesian KG, Madigan JE: Volume replacement in the neonatal ICU: crystalloids and colloids, Clin Tech Equine Tract 2(1):20-30, 2003.
2. Palmer JE: Fluid therapy in the neonate: not your mother’s fluid space, Vet Clin North Am Equme Tract 20(1):63-75, 2004.
3. Axon JE: Critical care - treatment. In McKinnon AO, Squires E, Vaala W, et al, editors: Equine reproduction, ed 2, Chichester, 2011, Wiley- Blackwell, pp 189-197.
4. Corley KTT: Monitoring and treating haemodynamic disturbances in critically ill neonatal foals. Part 2: assessment and treatment, Equine Vet Educ 14(6):328-336, 2002.
5. Fielding CL, Magdesian KG, Edman JE: Determination of body water compartments in neonatal foals by use of indicator dilution techniques and multifrequency bioelectrical impedance analysis, Am J Vet Res 72(10):1390-1396, 2011.
6. Wong DM, Wilkins PA, Bain FT, et al: Neonatal encephalopathy in foals, Compend Contin Educ Tract Vet 33:E1-E10, 2011.
7. Corley KT: Inotropes and vasopressors in adults and foals, Vet Clin North Am Equine Tract 20(1):77-106, 2004.
8. Dickey EJ, McKenzie H, Johnson A, et al: Use of pressor therapy in 34 hypotensive critically ill neonatal foals, Aust Vet J 88(12):472-477, 2010.
9. Silver M, Comline RS: Fetal and placental O2 consumption and the uptake of different metabolites in the ruminant and horse during late gestation, Adv Exp Med Biol 75:731-736, 1976.
10. Ousey JC: Heat production and its clinical implications in neonates, Equine Vet J 22(2):69-72, 1990.
11. Baggot JD: Drug therapy in the neonatal foal, Vet Clin North Am Equine Tract 10(1):87-107, 1994.
12. Fielding CL, Magdesian KG, Elliott DA, et al: Use of multifrequency bioelectrical impedance analysis for estimation of total body water and extracellular and intracellular fluid volumes in horses, Am J Vet Res 65(3):320-326, 2004.
13. Spensley MS, Carlson GP, Harrold D: Plasma, red blood cell, total blood, and extracellular fluid volumes in healthy horse foals during growth, Am J Vet Res 48(12):1703-1707, 1987.
14. Koterba AM, Drummond WH, Kosch P: Intensive care of the neonatal foal, Vet Clin North Am Equine Tract 1(1):3-34, 1985.
15. Hintz HF, Hintz RL, Van Vleck LD: Growth rate of thoroughbreds, effect of age of dam, year and month of birth, and sex of foal, J Anim Sci 48(3):480-487, 1979.
16. Martin RG, McMeniman NP, Dowsett KF: Milk and water intakes of foals sucking grazing mares, Equine Vet J 24(4):295-299, 1992.
17. Weeren PR, Oldruitenborough-Oosterbaan van MMS, Barneveld A: The influence of birth weight, rate of weight gain and final achieved height and sex on the development of osteochondrotic lesions in a population of genetically predisposed warmblood foals, Equine Vet J 31(S31):26-30, 1999.
18. Jose-Cunilleras E, Viu J, Corradini I, et al: Energy expenditure of critically ill neonatal foals, Equine Vet J Suppl 41:48-51, 2012.
19. Smeak DD: The Chinese finger trap suture technique for fastening tubes and catheters, J Am Anim Hosp Assoc 26(2):215-218, 1990.
20. Dunkel B, McKenzie HC: Severe hypertriglyceridaemia in clinically ill horses: diagnosis, treatment and outcome, Equine Vet J 35(6):590-595,
2003.
21. Myers CJ, Magdesian KG, Kass PH, et al: Parenteral nutrition in neonatal foals: clinical description, complications and outcome in 53 foals (19952005), Vet J 181(2):137-144, 2009.
22. Hansen TO: Nutritional support: parenteral feeding. In Koterba AM, Drummond WH, Kosch PC, editors: Equine clinical neonatology, Philadelphia, 1990, Lea and Febiger, pp 747-762.
2 3. Valberg SJ, Ward TL, Rush B, et al: Glycogen branching enzyme deficiency in quarter horse foals, J Vet Intern Med 15(6):572-580, 2001.
24. Mayhew IG: Neurologic examination. In Mayhew IG, editor: Large animal neurology, ed 2, 2008, Wiley-Blackwell, pp 11-46.
25. MacKay RJ: Neurologic disorders of neonatal foals, Vet Clin North Am Equine Tract 21(2):387-406, vii, 2005.
26. Jesty SA, Palmer JE, Parente EJ, et al: Rupture of the gastrocnemius muscle in six foals, J Am Vet Med Assoc 227(12):1965-1968, 1929, 2005.
27. Moore RM, Kohn CW: Nutritional muscular dystrophy in foals, Compend Contin Educ Tract Vet 13:476, 1991.
28. Crisman MV, Wilcke JR, Sams RA, et al: Concentrations of phenylbutazone and oxyphenbutazone in post-parturient mares and their neonatal foals, J Vet Tharmacol Ther 14(3):330-334, 1991.
29. McGladdery AL, Cottrill CM, Rossdale PD: Effects on the fetus of sedative drugs administered to the mare, in Troceedings International Conference of Veterinary Terinatology 2:14, 1990.
30. Smith LJ, Schott IIHC: Xylazine-induced bradycardia, in Troceedings International Conference of Veterinary Terinatology 2:36, 1990.
31. Scofield DB, Alexander DL, Franklin RP, et al: Review of fatalities and adverse reactions after administration of α-2 adrenergic agonist reversal agents in the horse, Troc Am Assoc Equine Tract 56:44-49, 2010.
32. Beyer MJ, Freestone JF, Reimer JM, et al: Idiopathic hypocalcemia in foals, J Vet Intern Med 11(6):356-360, 1997.
33. Mayhew IG, Watson AG, Heissan JA: Congenital occipitoatlantoaxial malformations in the horse, Equine Vet J 10(2):103-113, 1978.
34. Watson AG, Mayhew IG: Familial congenital occipitoatlantoaxial malformation (OAAM) in the arabian horse, Spine 11(4):334-339, 1986.
35. Giguere S, Cohen ND, Keith Chaffin M, et al: Diagnosis, treatment, control, and prevention of infections caused by rhodococcus equi in foals, J Vet Intern Med 25(6):1209-1220, 2011.
36. Carter GK, Martens RJ: Septicemia in the neonatal foal, Compend Contin Educ Tract Vet 8:S256-S270, 1986.
37. Paradis MR: Update on neonatal septicemia, Vet Clin North Am Equine Tract 10(1):109-135, 1994.
38. Bone RC, Balk RA, Cerra FB, et al: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM consensus conference committee. American college of chest Physicians/society of critical care medicine, Chest 101(6):1644-1655, 1992.
39. Wong DM, Wilkins PA: Defining the systemic inflammatory response syndrome in equine neonates, Vet Clin North Am Equine Tract 31(3):463-481,
2015.
40. Singer M, Deutschman CS, Seymour CW, et al: The third international consensus definitions for sepsis and septic shock (Sepsis-3), JAMA 315(8):801-810, 2016.
41. Haydar S, Spanier M, Weems P, et al: Comparison of QSOFA score and SIRS criteria as screening mechanisms for emergency department sepsis, Am J Emerg Med 35(11):1730-1733, 2017.
42. Williams JM, Greenslade JH, McKenzie JV, et al: Systemic inflammatory response syndrome, Quick sequential organ function assessment, and organ dysfunction: insights from a prospective database of ED patients with infection, Chest 151(3):586-596, 2017.
43. Corley KT, Pearce G, Magdesian KG, et al: Bacteraemia in neonatal foals: clinicopathological differences between Gram-positive and Gramnegative infections, and single organism and mixed infections, Equine Vet J 39(1):84-89, 2007.
44. Marsh PS, Palmer JE: Bacterial isolates from blood and their susceptibility patterns in critically ill foals: 543 cases (1991-1998), J Am Vet Med Assoc 218(10):1608-1610, 2001.
45. Sanchez LC, Giguere S, Lester GD: Factors associated with survival of neonatal foals with bacteremia and racing performance of surviving thoroughbreds: 423 cases (1982-2007), J Am Vet Med Assoc 233(9):1446- 1452, 2008.
46. Bentley AP, Barton MH, Lee MD, et al: Antimicrobial-induced endotoxin and cytokine activity in an in vitro model of septicemia in foals, Am J Vet Res 63(5):660-668, 2002.
47. Moore JN, Morris DD: Endotoxemia and septicemia in horses: experimental and clinical correlates, J Am Vet Med Assoc 200(12):1903-1914, 1992.
48. Pusterla N, Magdesian KG, Mapes S, et al: Expression of molecular markers in blood of neonatal foals with sepsis, Am J Vet Res 67(6):1045-1049,
2006.
49. Gold JR, Perkins GA, Erb HN, et al: Cytokine profiles of peripheral blood mononuclear cells isolated from septic and healthy neonatal foals, J Vet Intern Med 21(3):482-488, 2007.
50. Stewart AJ, Hinchcliff KW, Saville WJ, et al: Actinobacillus sp. bacteremia in foals: clinical signs and prognosis, J Vet Intern Med 16(4):464-471, 2002.
51. Wohlfender FD, Barrelet FE, Doherr MG, et al: Diseases in neonatal foals. Part 2: potential risk factors for a higher incidence of infectious diseases during the first 30 days post partum, Equine Vet J 41(2):186-191, 2009.
52. LeBlanc MM, Macpherson M, Sheerin P: Ascending placentitis; what we know about pathophysiology, diagnosis, and treatment, Troc Am Assoc Equine Tract 50:127-143, 2004.
53. Clabough DL, Levine JF, Grant GL, et al: Factors associated with failure of passive transfer of colostral antibodies in standardbred foals, J Vet Intern Med 5(6):335-340, 1991.
54. Raidal SL: The incidence and consequences of failure of passive transfer of immunity on a thoroughbred breeding farm, Aust Vet J 73(6):201-206, 1996.
55. Robinson JA, Allen GK, Green EM, et al: A prospective study of septicaemia in colostrum-deprived foals, Equine Vet J 25(3):214-219, 1993.
56. Tyler-McGowan CM, Hodgson JL, Hodgson DR: Failure of passive transfer in foals: incidence and outcome on four studs in New South Wales, Aust Vet J 75(1):56-59, 1997.
57. Hytychova T, Bezdekova B: Retrospective evaluation of blood culture isolates and sepsis survival rate in foals in the Czech Republic: 50 cases (2011-2013), J Vet Emerg Crit Care (San Antonio) 25(5):660-666, 2015.
58. Baldwin JL, Cooper WL, Vanderwall DK, et al: Prevalence (treatment days) and severity of illness in hypogammaglobulinemic and normogam- maglobulinemic foals, J Am Vet Med Assoc 198(3):423-428, 1991.
59. Madigan JE: Method for preventing neonatal septicemia, the leading cause of death in the neonatal foal, Troc Am Assoc Equine Tract 1997.
60. Jeffcott LB: Studies on passive immunity in the foal: II. The absorption of 125i-labelled PVP (polyvinyl pyrrolidone) by the neonatal intestine, J Comp Tathol 84(3):279-289, 1974.
61. Jeffcott LB: Passive immunity and its transfer with special reference to the horse, Biol Rev Camb Thilos Soc 47(4):439-464, 1972.
62. Rundell JO, Lecce JG: Independence of intestinal epithelial cell turnover from cessation of absorption of macromolecules (closure) in the neonatal mouse, rabbit, hamster and Guinea pig, Biol Neonate 20(1):51-57, 1972.
63. Raidal SL, McTaggart C, Penhale J: Effect of withholding macromolecules on the duration of intestinal permeability to colostral IgG in foals, Aust Vet J 83(1-2):78-81, 2005.
64. Brewer BD: Neonatal infection. In Koterba AM, Drummond WH, Kosch PC, editors: Equine clinical neonatalology, 1990, pp 295-316.
65. Henson S, Barton M: Bacterial isolates and antibiotic sensitivity patterns from septicemic neonatal foals: a 15 year retrospective study (1986-2000), in Proceedings of Havemeyer Foundation, Neonatal Septicemia Workshop 3:350-352, 2001.
66. Koterba AM, Brewer BD, Tarplee FA: Clinical and clinicopathological characteristics of the septicaemic neonatal foal: review of 38 cases, Equine Vet J 16(4):376-382, 1984.
67. Raisis AL, Hodgson JL, Hodgson DR: Equine neonatal septicaemia: 24 cases, Aust Vet J 73(4):137-140, 1996.
68. Russell CM, Axon JE, Blishen A, et al: Blood culture isolates and antimicrobial sensitivities from 427 critically ill neonatal foals, Aust Vet J 86(7):266-271, 2008.
69. Wilson WD, Madigan JE: Comparison of bacteriologic culture of blood and necropsy specimens for determining the cause of foal septicemia: 47 cases (1978-1987), J Am Vet Med Assoc 195(12):1759-1763, 1989.
70. Borchers A, Wilkins PA, Marsh PM, et al: Association of admission L-lactate concentration in hospitalised equine neonates with presenting complaint, periparturient events, clinical diagnosis and outcome: a prospective multicentre study, Equine Vet J Suppl 41:57-63, 2012.
71. Castanheira CIGD. 2017. The influence of gender in the prevalence of neonatal sepsis in horses: a retrospective study of 85 cases. Faculdade de Medicina Veterinaria PhD.
72. Theelen MJ, Wilson WD, Edman JM, et al: Temporal trends in prevalence of bacteria isolated from foals with sepsis: 1979-2010, Equine Vet J 46(2):169-173, 2014.
7 3. Toombs-Ruane LJ, Riley CB, Kendall AT, et al: Antimicrobial susceptibility of bacteria isolated from neonatal foal samples submitted to a New Zealand veterinary pathology laboratory (2004 to 2013), NZ Vet J 64(2):107-111,
2016.
74. Wong DM, Ruby RE, Dembek KA, et al: Evaluation of updated sepsis scoring systems and systemic inflammatory response syndrome criteria and their association with sepsis in equine neonates, J Vet Intern Med 2018.
75. McClureJJ, Addison JD, Miller RI: Immunodeficiency manifested by oral candidiasis and bacterial septicemia in foals, J Am Vet Med Assoc 186(11):1195-1197, 1985.
76. Reilly LK, Palmer JE: Systemic candidiasis in four foals, J Am Vet Med Assoc 205(3):464-466, 1994.
77. Dembek KA, Timko KJ, Johnson LM, et al: Steroids, steroid precursors, and neuroactive steroids in critically ill equine neonates, Vet J 225:42-49,
2017.
78. Barton MH, Morris DD, Norton N, et al: Hemostatic and fibrinolytic indices in neonatal foals with presumed septicemia, J Vet Intern Med 12(1):26-35, 1998.
79. Corley KT, Donaldson LL, Furr MO: Arterial lactate concentration, hospital survival, sepsis and SIRS in critically ill neonatal foals, Equine Vet J 37(1):53-59, 2005.
80. Berryhill EH, Magdesian KG, Kass PH, et al: Triglyceride concentrations in neonatal foals: serial measurement and effects of age and illness, Vet J 227:23-29, 2017.
81. Viu J, Armengou L, Rios J, et al: Acid base imbalances in ill neonatal foals and their association with survival, Equine Vet J 49(1):51-57, 2017.
82. Armengou L, Monreal L, Tarancon I, et al: Plasma D-dimer concentration in sick newborn foals, J Vet Intern Med 22(2):411-417, 2008.
83. Cotovio M, Monreal L, Armengou L, et al: Fibrin deposits and organ failure in newborn foals with severe septicemia, J Vet Intern Med 22(6):1403-1410, 2008.
84. Borchers A, Magdesian KG, Schenck PA, et al: Serial plasma vasopressin concentration in healthy and hospitalised neonatal foals, Equine Vet J 46(3):306-310, 2014.
85. Armengou L, Jose-Cunilleras E, Rios J, et al: Metabolic and endocrine profiles in sick neonatal foals are related to survival, J Vet Intern Med 27(3):567-575, 2013.
86. Gold JR, Divers TJ, Barton MH, et al: Plasma adrenocorticotropin, cortisol, and adrenocorticotropin/cortisol ratios in septic and normal-term foals, J Vet Intern Med 21(4):791-796, 2007.
87. Hart KA, Slovis NM, Barton MH: Hypothalamic-pituitary-adrenal axis dysfunction in hospitalized neonatal foals, J Vet Intern Med 23(4):901-912, 2009.
88. Hart KA, Barton MH, Ferguson DC, et al: Serum free cortisol fraction in healthy and septic neonatal foals, J Vet Intern Med 25(2):345-355, 2011.
89. Hurcombe SD, Toribio RE, Slovis N, et al: Blood arginine vasopressin, adrenocorticotropin hormone, and cortisol concentrations at admission in septic and critically iil foals and their association with survival, J Vet Intern Med 22(3):639-647, 2008.
90. Panzani S, Villani M, McGladdery A, et al: Concentrations of 15-keto- dihydro-PGF2alpha, cortisol, and progesterone in the plasma of healthy and pathologic newborn foals, Theriogenology 72(8):1032-1040, 2009.
91. Wong DM, Vo DT, Alcott CJ, et al: Baseline plasma cortisol and ACTH concentrations and response to low-dose ACTH stimulation testing in ill foals, J Am Vet Med Assoc 234(1):126-132, 2009.
92. Barsnick RJ, Hurcombe SD, Dembek K, et al: Somatotropic axis resistance and ghrelin in critically ill foals, Equine Vet J 46(1):45-49, 2014.
93. Kamr AM, Dembek KA, Reed SM, et al: Vitamin D metabolites and their association with calcium, Phosphorus, and PTH concentrations, Severity of illness, and mortality in hospitalized equine neonates, PLoS ONE 10(6):e0127684, 2015.
94. Lorenzo-Figueras M, Pusterla N, Byrne BA, et al: In vitro evaluation of three bacterial culture systems for the recovery of Escherichia coli from equine blood, Am J Vet Res 67(12):2025-2029, 2006.
95. Hackett ES, Lunn DP, Ferris RA, et al: Detection of bacteraemia and host response in healthy neonatal foals, Equine Vet J 47(4):405-409, 2015.
96. Brewer BD, Koterba AM, Carter RL, et al: Comparison of empirically developed sepsis score with a computer generated and weighted scoring system for the identification of sepsis in the equine neonate, Equine Vet J 20(1):23-24, 1988.
97. Brewer BD, Koterba AM: Development of a scoring system for the early diagnosis of equine neonatal sepsis, Equine Vet J 20(1):18-22, 1988.
98. Corley KTT, Furr MO: Evaluation of a score designed to predict sepsis in foals, J Vet Emerg Crit Care 13(3):149-155, 2003.
99. Weber EJ, Sanchez LC, Giguere S: Re-evaluation of the sepsis score in equine neonates, Equine Vet J 47(3):275-278, 2015.
100. Morris DD, Rutkowski J, Lloyd KC: Therapy in two cases of neonatal foal septicaemia and meningitis with cefotaxime sodium, Equine Vet J 19(2):151-154, 1987.
101. Neil KM, Axon JE, Begg AP, et al: Retrospective study of 108 foals with septic osteomyelitis, Aust Vet J 88(1-2):4-12, 2010.
102. Brown MP, Gronwall R, Kroll WR, et al: Ampicillin trihydrate in foals: serum concentrations and clearance after a single oral dose, Equine Vet J 16(4):371-373, 1984.
103. Duffee NE, Christensen JM, Craig AM: The pharmacokinetics of cefadroxil in the foal, J Vet Pharmacol Ther 12(3):322-326, 1989.
104. Duffee NE, Stang BE, Schaeffer DJ: The pharmacokinetics of cefadroxil over a range of oral doses and animal ages in the foal, J Vet Pharmacol Ther 20(6):427-433, 1997.
105. Henry MM, Morris DD, Lakritz J, et al: Pharmacokinetics of cephradine in neonatal foals after single oral dosing, Equine Vet J 24(3):242-243, 1992.
106. Carrillo NA, Giguere S, Gronwall RR, et al: Disposition of orally administered cefpodoxime proxetil in foals and adult horses and minimum inhibitory concentration of the drug against common bacterial pathogens of horses, Am J Vet Res 66(1):30-35, 2005.
107. Rohdich N, Zschiesche E, Heckeroth A, et al: Treatment of septicaemia and severe bacterial infections in foals with a new cefquinome formulation: a field study, Dtsch Tierarztl Wochenschr 116(9):316-320, 2009.
108. Thomas E, Thomas V, Wilhelm C: Antibacterial activity of cefquinome against equine bacterial pathogens, Vet Microbiol 115(1-3):140-147, 2006.
109. Davenport CL, Boston RC, Richardson DW: Effects of enrofloxacin and magnesium deficiency on matrix metabolism in equine articular cartilage, Am J Vet Res 62(2):160-166, 2001.
110. Vivrette SL, Bostian A, Bermingham E, et al: Quinolone-induced arthropathy in neonatal foals, Proc Am Assoc Equine Pract 47:376-377, 2001.
111. Hendrix DVH, Ward DA, Guglick MA: Disseminated candidiasis in a neonatal foal with keratomycosis as the initial sign, Vet Comp Ophthalmol 7:1997.
112. Hilton H, Galuppo L, Puchalski SM, et al: Successful treatment of invasive pulmonary aspergillosis in a neonatal foal, J Vet Intern Med 23(2):375-378, 2009.
113. Baskett A, Barton MH, Norton N, et al: Effect of pentoxifylline, flunixin meglumine, and their combination on a model of endotoxemia in horses, Am J Vet Res 58(11):1291-1299, 1997.
114. Morresey PR, Mackay RJ: Endotoxin-neutralizing activity of polymyxin B in blood after IV administration in horses, Am J Vet Res 67(4):642-647, 2006.
115. Wong DM, Sponseller BA, Alcott CJ, et al: Effects of intravenous administration of polymyxin B in neonatal foals with experimental endotoxemia, J Am Vet Med Assoc 243(6):874-881, 2013.
116. Cruz DN, Perazella MA, Bellomo R, et al: Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review, Crit Care 11(2):R47, 2007.
117. Haque K, Mohan P: Pentoxifylline for neonatal sepsis, Cochrane Database Syst Rev (4):CD004205, 2003.
118. Staubach KH, Schroder J, Stuber F, et al: Effect of pentoxifylline in severe sepsis: results of a randomized, double-blind, placebo-controlled study, Arch Surg 133(1):94-100, 1998.
119. Hartog CS, Bauer M, Reinhart K: The efficacy and safety of colloid resuscitation in the critically ill, Anesth Analg 112(1):156-164, 2011.
120. Reinhart K, Perner A, Sprung CL, et al: Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients, Intensive Care Med 38(3):368-383, 2012.
121. Epstein KL, Bergren A, Giguere S, et al: Cardiovascular, colloid osmotic pressure, and hemostatic effects of 2 formulations of hydroxyethyl starch in healthy horses, J Vet Intern Med 28(1):223-233, 2014.
122. Gratwick Z, Viljoen A, Page PC, et al: A comparison of the effects of a 4% modified fluid gelatin and a 6% hydroxyethyl starch on haemodilution, colloid osmotic pressure, haemostasis and renal parameters in healthy ponies, Equine Vet J 49(3):363-368, 2017.
123. Hepworth-Warren KL, Wong DM, Hay-Kraus BL, et al: Effects of administration of a synthetic low molecular weight/low molar substitution hydroxyethyl starch solution in healthy neonatal foals, Can Vet J 56(10):1069-1074, 2015.
124. Magdesian KG: Monitoring the critically ill equine patient, Vet Clin North Am Equine Pract 20(1):11-39, 2004.
125. Lee CW, Kory PD, Arntfield RT: Development of a fluid resuscitation protocol using inferior vena cava and lung ultrasound, J Crit Care 31(1):96-100, 2016.
126. Lichtenstein D, Karakitsos D: Integrating lung ultrasound in the hemodynamic evaluation of acute circulatory failure (the fluid administration limited by lung sonography protocol), J Crit Care 27(5):533, e11-e19,
2012.
127. Tuplin MC, Romero AE, Boysen SR: Influence of the respiratory cycle on caudal vena cava diameter measured by sonography in healthy foals: a pilot study, J Vet Intern Med 31(5):1556-1562, 2017.
128. Arise I, Anzics CTG, Peake SL, et al: Goal-directed resuscitation for patients with early septic shock, NEngl J Med 371(16):1496-1506, 2014.
129. Mouncey PR, Osborn TM, Power GS, et al: Protocolised management in sepsis (ProMISe): a multicentre randomised controlled trial of the clinical effectiveness and cost-effectiveness of early, goal-directed, pro- tocolised resuscitation for emerging septic shock, Health Technol Assess 19(97):i-xxv, 1, 2015.
130. ProCESS I, Yealy DM, Kellum JA, et al: A randomized trial of protocolbased care for early septic shock, N Engl J Med 370(18):1683-1693, 2014.
131. Sanchez LC, Lester GD, Merritt AM: Effect of ranitidine on intragastric pH in clinically normal neonatal foals, JAm Vt MedAssoc 212(9):1407-1412, 1998.
132. Sanchez LC, Lester GD, Merritt AM: Intragastric pH in critically ill neonatal foals and the effect of ranitidine, J Am Vet Med Assoc 218(6):907-911, 2001.
133. Dinsmore JE, Jackson RJ, Smith SD: The protective role of gastric acidity in neonatal bacterial translocation, J Pediatr Surg 32(7):1014-1016, 1997.
134. Furr M, Cohen ND, Axon JE, et al: Treatment with histamine-type 2 receptor antagonists and omeprazole increase the risk of diarrhoea in neonatal foals treated in intensive care units, Equine Vet J Suppl 44(Suppl 41):80-86, 2012.
135. Javsicas LH, Sanchez LC: The effect of omeprazole paste on intragastric pH in clinically ill neonatal foals, Equine Vet J 40(1):41-44, 2008.
136. Ryan CA, Sanchez LC, Giguere S, et al: Pharmacokinetics and pharmacodynamics of pantoprazole in clinically normal neonatal foals, Equine Vet J 37(4):336-341, 2005.
137. Sanchez LC, Murray MJ, Merritt AM: Effect of omeprazole paste on intragastric pH in clinically normal neonatal foals, Am J Vet Res 65(8):1039-1041, 2004.
138. Marik PE, Khangoora V, Rivera R, et al: Hydrocortisone, Vitamin C, and thiamine for the treatment of severe sepsis and septic shock: a retrospective Before-after study, Chest 151(6):1229-1238, 2017.
139. Armengou L, Monreal L, Delgado MA, et al: Low-molecular-weight heparin dosage in newborn foals, J Vet Intern Med 24(5):1190-1195, 2010.
140. Freeman L, Paradis MR: Evaluating the effectiveness of equine neonatal care, Vet Med 87:921-926, 1992.
141. Gayle JM, Cohen ND, Chaffin MK: Factors associated with survival in septicemic foals: 65 cases (1988-1995), J Vet Intern Med 12(3):140-146, 1998.
142. Frederick J, Giguere S, Sanchez LC: Infectious agents detected in the feces of diarrheic foals: a retrospective study of 233 cases (2003-2008), J Vet Intern Med 23(6):1254-1260, 2009.
143. Hollis AR, Wilkins PA, Palmer JE, et al: Bacteremia in equine neonatal diarrhea: a retrospective study (1990-2007), J Vet Intern Med 22(5):1203-1209,
2008.
144. Leiva M, Pena T, Armengou L, et al: Uveal inflammation in septic newborn foals, J Vet Intern Med 24(2):391-397, 2010.
145. Brianceau P, Divers TJ: Acute thrombosis of limb arteries in horses with sepsis: five cases (1988-1998), Equine Vet J 33(1):105-109, 2001.
146. Forrest LJ, Cooley AJ, Darien BJ: Digital arterial thrombosis in a septicemic foal, J Vet Intern Med 13(4):382-385, 1999.
147. Moore LA, Johnson PJ, Bailey KL: Aorto-iliac thrombosis in a foal, Vet Rec 142(17):459-462, 1998.
148. Triplett EA, O’Brien RT, Wilson DG, et al: Thrombosis of the brachial artery in a foal, J Vet Intern Med 10(5):330-332, 1996.
149. Brewer BD, Koterba AM: Bacterial isolates and susceptibility patterns in foals in a neonatal intensive care unit, Compend Contin Educ Pract Vet 12(12):1773-1781, 1990.
150. Axon JE, Palmer J, Wilkins P: Short-and long-term athletic outcome of neonatal intensive care unit survivors, Proc Am Assoc Equine Pract 45:224-225, 1999.
151. Borchers A, Wilkins PA, Marsh PM, et al: Sequential L-lactate concentration in hospitalised equine neonates: a prospective multicentre study, Equine Vet J Suppl 45:2-7, 2013.
152. Garcia-Alvarez M, Marik P, Bellomo R: Sepsis-associated hyperlactatemia, Crit Care 18(5):503, 2014.
153. Suetrong B, Walley KR: Lactic acidosis in sepsis: It’s not all anaerobic: implications for diagnosis and management, Chest 149(1):252-261, 2016.
154. Wilkins PA, Sheahan BJ, Vander Werf KA, et al: Preliminary investigation of the area under the L-lactate concentration-time curve (LACArea) in critically ill equine neonates, J Vet Intern Med 29(2):659-662, 2015.
155. Dembek KA, Hurcombe SD, Frazer ML, et al: Development of a likelihood of survival scoring system for hospitalized equine neonates using generalized boosted regression modeling, PLoS ONE 9(10):e109212, 2014.
156. Rohrbach BW, Buchanan BR, Drake JM, et al: Use of a multivariable model to estimate the probability of discharge in hospitalized foals that are 7 days of age or less, J Am Vet Med Assoc 228(11):1748-1756, 2006.
157. Corley KT, Corley MM: Hospital treatment as a foal does not adversely affect future sales performance in thoroughbred horses, Equine Vet J Suppl 44(Suppl 41):87-90, 2012.
158. Francesca F, Jole M, Aliai L, et al: Efficacy and safety of a commercial fresh-frozen hyperimmune plasma in foals with failure of passive transfer of immunity, J Equine Vet Sci 48:174-181, e2, 2017.
159. Mullany LC, Darmstadt GL, Tielsch JM: Role of antimicrobial applications to the umbilical cord in neonates to prevent bacterial colonization and infection: a review of the evidence, Pediatr Infect Dis J 22(11):996-1002, 2003.
160. Martens RJ, Auer JA, Carter GK: Equine pediatrics: septic arthritis and osteomyelitis, J Am Vet Med Assoc 188(6):582-585, 1986.
161. Platt H: Septicaemia in the foal. A review of 61 cases, Br Vet J 129(3):221-229, 1973.
162. Hepworth-Warren KL, Wong DM, Fulkerson CV, et al: Bacterial isolates, antimicrobial susceptibility patterns, and factors associated with infection and outcome in foals with septic arthritis: 83 cases (1998-2013), J Am Vet Med Assoc 246(7):785-793, 2015.
163. Meijer MC, Weeren PRV, Rijkenhuizen ABM: Clinical experiences of treating septic arthritis in the equine by repeated joint lavage: a series of 39 cases, J Vet Med A Physiol Pathol Clin Med 47(6):351-365, 2000.
164. Neil KM, Axon JE, Todhunter PG, et al: Septic osteitis of the distal phalanx in foals: 22 cases (1995-2002), J Am Vet Med Assoc 230(11):1683-1690,
2007.
165. Schneider RK, Bramlage LR, Moore RM, et al: A retrospective study of 192 horses affected with septic arthritis/tenosynovitis, Equine Vet J 24(6):436-442, 1992.
166. Steel CM, Hunt AR, Adams PL, et al: Factors associated with prognosis for survival and athletic use in foals with septic arthritis: 93 cases (19871994), J Am Vet Med Assoc 215(7):973, 1999.
167. Smith LJ, Marr CM, Payne RJ, et al: What is the likelihood that thoroughbred foals treated for septic arthritis will race?, Equine Vet J 36(5):452-456, 2004.
168. Firth EC: Current concepts of infectious polyarthritis in foals, Equine Vet J 15(1):5-9, 1983.
169. Annear MJ, Furr MO: Septic arthritis in foals, Equine Vet Educ 23(8):422-431,
2011.
170. Glass K, Watts AE: Septic arthritis, Physitis, and osteomyelitis in foals, Vet Clin North Am Equine Pract 33(2):299-314, 2017.
171. Hardy J: Etiology, diagnosis, and treatment of septic arthritis, osteitis, and osteomyelitis in foals, Clin Tech Equine Pract 5(4):309-317, 2006.
172. Trumble TN: Orthopedic disorders in neonatal foals, Vet Clin North Am Equine Pract 21(2):357-385, vi, 2005.
173. Smith LJ, Marr CM, Payne RJ, et al: What is the likelihood that thoroughbred foals treated for septic arthritis will race?, Equine Vet J 36(5):452-456, 2004.
174. Stoneham SJ: Septic arthritis in the foal: practical considerations on diagnosis and treatment, Equine Vet Educ 9(1):25-29, 1997.
175. Newquist JM, Baxter GM: Evaluation of plasma fibrinogen concentration as an indicator of physeal or epiphyseal osteomyelitis in foals: 17 cases (2002-2007), J Am Vet Med Assoc 235(4):415-419, 2009.
176. Adkins AR: Establishing a diagnosis of septic arthritis/osteomyelitis-a challenging process, Equine Vet Educ 24:615, 2012.
177. Bertone AL: Update on infectious arthritis in horses, Equine Vet Educ 11(3):143-152, 1999.
178. Madison JB, Sommer M, Spencer PA: Relations among synovial membrane histopathologic findings, synovial fluid cytologic findings, and bacterial culture results in horses with suspected infectious arthritis: 64 cases (1979-1987), J Am Vet Med Assoc 198(9):1655, 1991.
179. Walmsley EA, Anderson GA, Muurlink MA, et al: Retrospective investigation of prognostic indicators for adult horses with infection of a synovial structure, Aust Vet J 89(6):226-231, 2011.
180. Martin BBJ, Reef VB, Parente EJ, et al: Causes of poor performance of horses during training, racing, or showing: 348 cases (1992-1996), J Am Vet Med Assoc 216(4):554-558, 2000.
181. Vivrette SL, Bostian A, Bermingham E, et al: Quinolone-induced arthropathy in neonatal foals, Proc Am Assoc Equine Pract 47:376-377, 2001.
182. Yoon JH, Brooks RL, Khan A, et al: The effect of enrofloxacin on cell proliferation and proteoglycans in horse tendon cells, Cell Biol Toxicol 20(1):41-54, 2004.
183. Lawrence CP, Fraser BSL: Septic osteitis of the axial border of the proximal sesamoid bones in two foals, Equine Vet Educ 25(2):63-66, 2013.
184. Butt TD, Bailey JV, Dowling P, et al: Comparison of 2 techniques for regional antibiotic delivery to the equine forelimb: intraosseous perfusion vs. intravenous perfusion, Can Vet J 42(8):617, 2001.
185. Pille F, Baere S, Ceelen L, et al: Synovial fluid and plasma concentrations of ceftiofur after regional intravenous perfusion in the horse, Vet Surg 34(6):610-617, 2005.
186. Rubio-Martinez LM, Elmas CR, Black B, et al: Clinical use of antimicrobial regional limb perfusion in horses: 174 cases (1999-2009), J Am Vet Med Assoc 241(12):1650-1658, 2012.
187. Lescun TB, Vasey JR, Ward MP, et al: Treatment with continuous intrasynovial antimicrobial infusion for septic synovitis in horses: 31 cases (2000-2003), J Am Vet Med Assoc 228(12):1922-1929, 2006.
188. Hall MS, Pollock PJ, Russell T: Surgical treatment of septic physitis in 17 foals, Aust Vet J 90(12):479-484, 2012.
189. Kay AT, Hunt RJ, Rodgerson DH, et al: Osteomyelitis of the patella in eight foals, Vet Surg 41(2):307-315, 2012.
190. Raidal SL, Edwards S, Pippia J, et al: Pharmacokinetics and safety of oral administration of meloxicam to foals, J Vet Intern Med 27(2):300-307,
2013.
191. McGowan KT, Elfenbein JR, Robertson SA, et al: Effect of butorphanol on thermal nociceptive threshold in healthy pony foals, Equine Vet J
2012.
192. Adkins AR: Fractures commonly seen in foals. In McKinnon AO, Squires EL, Vaala WE, et al, editors: Equine reproduction, ed 2, Chichester, 2011, Wiley-Blackwell, pp 446-456.
193. Crowe MW, Swerczek TW: Equine congenital defects, Am J Vet Res 46(2):353, 1985.
194. Green SL, Mayhew IJ: Neurologic disorders. In Koterba AM, Drummond WH, Kosch PC, editors: Equine clinical neonatology, Philadelphia, 1990, Lea and Febiger, pp 505-508.
195. Adams R, Mayhew IG: Neurologic disease, Vet Clin North Am Equine Prac 1(1):209, 1985.
196. Cudd TA: Agenesis of the corpus callosum with cerebellar vermian hypoplasia in a foal resembling the Dandy-walker syndrome: pre-mortem diagnosis by clinical evaluation and CT scanning, Equine Vet J 22(5):328, 1990.
197. Bernard WV, Reimer JM, Cudd T, et al: Historical factors, clinicopathologic findings, clinical features, and outcome of equine neonates presenting with or developing signs of central nervous system disease, Proc Am Assoc Equtne Pract 41:222-224, 1995.
198. Aleman M, Pickles KJ, Conley AJ, et al: Abnormal plasma neuroactive progestagen derivatives in ill, neonatal foals presented to the neonatal intensive care unit, Equine Vet J 45(6):661-665, 2013.
199. Ferriero DM: Neonatal brain injury, NEngl J Med 351(19):1985-1995,
2004.
200. Rossdale PD, Ousey JC, McGladdery AJ, et al: A retrospective study of increased plasma progestagen concentrations in compromised neonatal foals, Reprod Ferttl Dev 7(3):567-575, 1995.
201. Yildiz EP, Ekici B, Tatli B: Neonatal hypoxic ischemic encephalopathy: an update on disease pathogenesis and treatment, Expert Rev Neurother 17(5):449-459, 2017.
202. Thornton C, Jones A, Nair S, et al: Mitochondrial dynamics, mitophagy and biogenesis in neonatal hypoxic-ischaemic brain injury, FEBS Lett 592(5):812-830, 2018.
203. Li B, Concepcion K, Meng X, et al: Brain-immune interactions in perinatal hypoxic-ischemic brain injury, Prog Neurobiol 159:50-68, 2017.
204. Allen KA, Brandon DH: Hypoxic ischemic encephalopathy: pathophysiology and experimental treatments, Newborn Infant Nurs Rev 11(3):125-133, 2011.
205. Inder TE, Volpe JJ: Mechanisms of perinatal brain injury, Semin Neonatol 5(1):3-16, 2000.
206. Mishra OP, Fritz KI, Delivoria-Papadopoulos M: NMDA receptor and neonatal hypoxic brain injury, Ment Retard Dev Disabil Res Rev 7(4):249-253, 2001.
207. Horn M, Schlote W: Delayed neuronal death and delayed neuronal recovery in the human brain following global ischemia, Acta Neuropathol 85(1):79-87, 1992.
208. Johnston MV: Excitotoxicity in perinatal brain injury, Brain Pathol 15(3):234-240, 2005.
209. Zhao M, Zhu P, Fujino M, et al: Oxidative stress in Hypoxic-ischemic encephalopathy: molecular mechanisms and therapeutic strategies, Int J Mol Sci 17(12):2016.
209a. Galvin N, Collins D: Perinatal asphyxia syndrome in the foal: review and a case report, Irish Vet J 57:707-714, 2004.
210. Calvert JW, Zhang JH: Pathophysiology of an hypoxic-ischemic insult during the perinatal period, Neurol Res 27(3):246-260, 2005.
211. Beckman JS, Viera L, Estevez AG, et al: Nitric oxide and peroxynitrite in the perinatal period, Semin Perinatol 24(1):37-41, 2000.
212. Fatemi A, Wilson MA, Johnston MV: Hypoxic-ischemic encephalopathy in the term infant, Clin Perinatol 36(4):835-858, vii, 2009.
213. Alvarez-Diaz A, Hilario E, de Cerio FG, et al: Hypoxic-ischemic injury in the immature brain-key vascular and cellular players, Neonatology 92(4):227-235, 2007.
214. Madigan JE, Haggettt EF, Pickles KJ, et al: Allopregnanolone infusion induced neurobehavioural alterations in a neonatal foal: is this a clue to the pathogenesis of neonatal maladjustment syndrome, Equine Vet J Suppl 41:109-112, 2012.
215. Warnes KE, McMillen IC, Robinson JS, et al: Differential actions of metyrapone on the fetal pituitary-adrenal axis in the sheep fetus in late gestation, Biol Reprod 71(2):620-628, 2004.
216. Houghton E, Holtan D, Grainger L, et al: Plasma progestagen concentrations in the normal and dysmature newborn foal, J Reprod Fertil Suppl 44:609-617, 1991.
217. Zhu D, Wang MD, Backstrom T, et al: Evaluation and comparison of the pharmacokinetic and pharmacodynamic properties of allopregnenolone and pregnenolone at induction of anaesthesia in the male rat, Br J Anaesth 86(3):403-412, 2001.
218. Aleman M, Weich KM, Madigan JE: Survey of veterinarians using a novel physical compression squeeze procedure in the management of neonatal maladjustment syndrome in foals, Animals (Basel) 7(9):2017.
219. Toth B, Aleman M, Brosnan RJ, et al: Evaluation of squeeze-induced somnolence in neonatal foals, Am J Vet Res 73(12):1881-1889, 2012.
220. Diesch TJ, Mellor DJ: Birth transitions: pathophysiology, the onset of consciousness and possible implications for neonatal maladjustment syndrome in the foal, Equine Vet J 45(6):656-660, 2013.
221. Mellor DJ, Lentle RG: Survival implications of the development of behavioural responsiveness and awareness in different groups of mammalian young, N Z Vet J 63(3):131-140, 2015.
222. Gotsch F, Romero R, Kusanovic JP, et al: The fetal inflammatory response syndrome, Clin Obstet Gynecol 50(3):652-683, 2007.
223. Spinillo A, Iacobone AD, Calvino IG, et al: The role of the placenta in feto-neonatal infections, Early Hum Dev 90(Suppl 1):S7-S9, 2014.
224. Leblanc MM, Giguere S, Lester GD, et al: Relationship between infection, inflammation and premature parturition in mares with experimentally induced placentitis, Equine Vet J 44(Suppl 41):8-14, 2012.
225. Furr MO: Perinatal asphyxia in foals, Compend Contin Educ Pract Vet 18:1342-1351, 1996.
226. Green SL: Current perspectives on equine neonatal maladjustment syndrome, Compend Contin Educ Pract Vet 15:1550-1552, 1993.
227. Vaala WE: Peripartum asphyxia, Vet Clin North Am Equine Pract 10(1):187-218, 1994.
228. Vaala WE: Peripartum asphyxia syndrome in foals, Proc Am Assoc Equine Pract 45:247-253, 1999.
229. Dickey EJ, Long SN, Hunt RW: Hypoxic ischemic encephalopathy-what can we learn from humans, J Vet Intern Med 25(6):1231-1240, 2011.
230. Lyle-Dugas J, Giguere S, Mallicote MF, et al: Factors associated with outcome in 94 hospitalised foals diagnosed with neonatal encephalopathy, Equine Vet J 49(2):207-210, 2017.
231. Holcombe SJ, Hurcombe SD, Barr BS, et al: Dysphagia associated with presumed pharyngeal dysfunction in 16 neonatal foals, Equine Vet J 44(s41):105-108, 2012.
232. Groenendaal F, de Vries LS: Fifty years of brain imaging in neonatal encephalopathy following perinatal asphyxia, Pediatr Res 81(1-2):150-155, 2017.
233. Lamblin MD, Walls Esquivel E, Andre M: The electroencephalogram of the full-term newborn: review of normal features and hypoxic-ischemic encephalopathy patterns, Neurophysiol Clin 43(5-6):267-287, 2013.
234. Barkovich AJ, Westmark K, Partridge C, et al: Perinatal asphyxia: MR findings in the first 10 days, AJNR Am J Neuroradiol 16(3):427-438, 1995.
235. Massaro AN: MRI for neurodevelopmental prognostication in the high-risk term infant, Semin Perinatol 39(2):159-167, 2015.
236. Miller SP, Ramaswamy V, Michelson D, et al: Patterns of brain injury in term neonatal encephalopathy, J Pediatr 146(4):453-460, 2005.
237. Sie LT, van der Knaap MS, Oosting J, et al: MR patterns of hypoxic- ischemic brain damage after prenatal, perinatal or postnatal asphyxia, Neuropediatrics 31(3):128-136, 2000.
238. Chaffin MK, Walker MA, McArthur NH, et al: Magnetic resonance imaging of the brain of normal neonatal foals, Vet Radiol Ultrasound 38(2):102-111, 1997.
239. Wong DM, Jeffery N, Hepworth-Warren KL, et al: Magnetic resonance imaging of presumptive neonatal encephalopathy in a foal, Equine Vet Educ 29(10):534-538, 2017.
240. Rutherford MA, Pennock JM, Dubowitz LM: Cranial ultrasound and magnetic resonance imaging in hypoxic-ischaemic encephalopathy: a comparison with outcome, Dev Med Child Neurol 36(9):813-825, 1994.
241. Mackenzie CJ, Haggett EF, Pinchbeck GL, et al: Ultrasonographic assessment of the atlanto-occipital space in healthy thoroughbred foals and thoroughbred foals with neonatal maladjustment syndrome, Vet J 223:55-59, 2017.
242. Lacombe VA, Podell M, Furr M, et al: Diagnostic validity of electroencephalography in equine intracranial disorders, J Vet Intern Med 15(4):385-393, 2001.
243. Sinclair DB, Campbell M, Byrne P, et al: EEG and long-term outcome of term infants with neonatal hypoxic-ischemic encephalopathy, Clin Neurophysiol 110(4):655-659, 1999.
244. Walsh BH, Murray DM, Boylan GB: The use of conventional EEG for the assessment of hypoxic ischaemic encephalopathy in the newborn: a review, Clin Neurophysiol 122(7):1284-1294, 2011.
245. Chaney KP, Holcombe SJ, Schott HC, et al: Spurious hypercreatininemia: 28 neonatal foals (2000-2008), J Vet Emerg Crit Care (San Antonio) 20(2):244-249, 2010.
246. Ringger NC, Giguere S, Morresey PR, et al: Biomarkers of brain injury in foals with hypoxic-ischemic encephalopathy, J Vet Intern Med 25(1):132-137, 2011.
247. Volpe JJ: Hypoxic-ischemic encephalopathy: clinical aspects. In Volpe JJ, editor: Newrology of the Newborn, ed 4, Philadelphia, 2001, WB Saunders, pp 331-394.
248. Volpe JJ: Perinatal brain injury: from pathogenesis to neuroprotection, Ment Retard Dev Disabil Res Rev 7(1):56-64, 2001.
249. Giguere S, Slade JK, Sanchez LC: Retrospective comparison of caffeine and doxapram for the treatment of hypercapnia in foals with hypoxic- ischemic encephalopathy, J Vet Intern Med 22(2):401-405, 2008.
250. Wilkins PA: How to use midazolam to control equine neonatal seizures, Proc Am Assoc Equine Pract 51:279-280, 2005.
251. MacDonald KD, Hart KA, Davis JL, et al: Pharmacokinetics of the anticonvulsant levetiracetam in neonatal foals, Equine Vet J 2017.
252. Liu XH, Yan H, Xu M, et al: Hyperbaric oxygenation reduces long-term brain injury and ameliorates behavioral function by suppression of apoptosis in a rat model of neonatal hypoxia-ischemia, Neurochem Int 62(7):922-930,
2013.
253. Orozco-Gutierrez A, Rojas-Cerda L, Estrada RM, et al: Hyperbaric oxygen in the treatment of asphyxia in two newborn infants, Diving Hyperb Med 40(4):218-220, 2010.
2 54. Slovis N: Hyperbaric oxygen therapy in horses, J Vet Intern Med 24:150-152, 2006.
255. Zhou BY, Lu GJ, Huang YQ, et al: Efficacy of hyperbaric oxygen therapy under different pressures on neonatal hypoxic-ischemic encephalopathy, Zhongguo Dang Dai Er Ke Za Zhi 10(2):133-135, 2008.
256. Wilkins PA: Disorders in foals. In Reed SM, Bayly WM, Sellon DC, editors: Equine internal medicine, ed 2, St. Louis, 2004, WB Sauders, pp 1381-1440.
257. Azzopardi DV, Strohm B, Edwards AD, et al: Moderate hypothermia to treat perinatal asphyxial encephalopathy, N Engl J Med 361(14):1349-1358,
2009.
258. Shankaran S, Pappas A, McDonald SA, et al: Childhood outcomes after hypothermia for neonatal encephalopathy, NEngl J Med 366(22):2085-2092, 2012.
259. Palmer AC, Rossdale PD: Neuropathological changes associated with the neonatal maladjustment syndrome in the thoroughbred foal, Res Vet Sci 20(3):267-275, 1976.
260. Stuart BP, Martin BR, Williams LPJ, et al: Salmonella-induced meningoencephalitis in a foal, J Am Vet Med Assoc 162(3):211-213, 1973.
261. Aleman M, Gray LC, Williams DC, et al: Juvenile idiopathic epilepsy in Egyptian arabian foals: 22 cases (1985-2005), J Vet Intern Med 20(6):1443-1449, 2006.
262. Aleman M, Finno CJ, Weich K, et al: Investigation of known genetic mutations of arabian horses in Egyptian arabian foals with juvenile idiopathic epilepsy, J Vet Intern Med 32(1):465-468, 2018.
263. Kallem VR, Pandita A, Gupta G: Hypoglycemia: when to treat, Clin Med Insights Pediatr 11:1179556517748913, 2017.
264. Bruenisholz H, Kupper J, Muentener CR, et al: Treatment of ivermectin overdose in a miniature shetland pony using intravenous administration of a lipid emulsion, J Vet Intern Med 26(2):407-411, 2012.
265. Godber LM, Derksen FJ, Williams JF, et al: Ivermectin toxicosis in a neonatal foal, Aust Vet J 72(5):191-192, 1995.
266. Plummer CE, Kallberg ME, Ollivier FJ, et al: Suspected ivermectin toxicosis in a miniature mule foal causing blindness, Vet Ophthalmol 9(1):29-32, 2006.
267. Johnson PJ, Mrad DR, Schwartz AJ, et al: Presumed moxidectin toxicosis in three foals, J Am Vet Med Assoc 214(5):678-680, 1999.
268. Muller JM, Feige K, Kastner SB, et al: The use of sarmazenil in the treatment of a moxidectin intoxication in a foal, J Vet Intern Med 19(3):348-349, 2005.
269. Loynachan AT, Williams NM, Freestone JF: Kernicterus in a neonatal foal, J Vet Diagn Invest 19(2):209-212, 2007.
270. Polkes AC, Giguere S, Lester GD, et al: Factors associated with outcome in foals with neonatal isoerythrolysis (72 cases, 1988-2003), J Vet Intern Med 2008.
271. Mancuso C: Bilirubin and brain: a pharmacological approach, Neuropharmacology 118:113-123, 2017.
272. Schwartz HP, Haberman BE, Ruddy RM: Hyperbilirubinemia: current guidelines and emerging therapies, Pediatr Emerg Care 27(9):884-889,
2011.
273. Polkes AC: Neonatal isoerythrolysis: overview, management strategies and long-term outcome, J Vet Intern Med 2003.
274. Kumar P, Adhisivam B, Vishnu Bhat B: Clofibrate as an adjunct to phototherapy for unconjugated hyperbilirubinemia in term neonates, Indian J Pediatr 84(10):763-767, 2017.
275. Page P, Parker R, Harper C, et al: Clinical, clinicopathologic, postmortem examination findings and familial history of 3 arabians with lavender foal syndrome, J Vet Intern Med 20(6):1491-1494, 2006.
276. Bierman A, Guthrie AJ, Harper CK: Lavender foal syndrome in arabian horses is caused by a single-base deletion in the MYO5A gene, Anim Genet 41:199-201, 2010.
277. Brooks SA, Gabreski N, Miller D, et al: Whole-genome SNP association in the horse: identification of a deletion in myosin va responsible for lavender foal syndrome, PLoS Genet 6(4):e1000909, 2010.
278. Fanelli HH: Coat colour dilution lethal (‘lavender foal syndrome’): a tetany syndrome of arabian foals, Equine Vet Educ 17(5):260- 263, 2005.
279. Finno CJ, Spier SJ, Valberg SJ: Equine diseases caused by known genetic mutations, Vet J 179(3):336-347, 2009.
280. Ward TL, Valberg SJ, Adelson DL, et al: Glycogen branching enzyme (GBE1) mutation causing equine glycogen storage disease IV, Mamm Genome 15(7):570-577, 2004.
281. Harvey JW, Asquith RL, McNulty PK, et al: Haematology of foals up to one year old, Equine Vet J 16(4):347-353, 1984.
282. Munoz A, Riber C, Trigo P, et al: Age- and gender-related variations in hematology, clinical biochemistry, and hormones in Spanish fillies and colts, Res Vet Sci 93(2):943-949, 2012.
283. Harvey JW, Asquith RL, Sussman WA, et al: Serum ferritin, serum iron, and erythrocyte values in foals, Am J Vet Res 48(9):1348-1352, 1987.
284. Kohn CW, Jacobs RM, Knight D, et al: Microcytosis, hypoferremia, hypoferritemia, and hypertransferrinemia in standardbred foals from birth to 4 months of age, Am J Vet Res 51(8):1198-1205, 1990.
285. Mullaney TP, Brown CM: Iron toxicity in neonatal foals, Equine Vet J 20(2):119-124, 1988.
286. Fleming KA, Barton MH, Latimer KS: Iron deficiency anemia in a neonatal foal, J Vet Intern Med 20(6):1495-1498, 2006.
287. Brommer H, Sloet van Oldruitenborgh-Oosterbaan MM: Iron deficiency in stabled Dutch warmblood foals, J Vet Intern Med 15(5):482-485, 2001.
288. Doarn RT, Threlfall WR, Kline R: Umbilical blood flow and the effects of premature severance in the neonatal horse, Theriogenology 28(6):789-800, 1987.
289. Muurlink MA, Walmsley JP, Savage CJ, et al: Splenectomy in a foal to control intra-abdominal haemorrhage caused by splenic rupture, Equine Vet Educ 20(7):362-366, 2008.
290. Green SL, Specht TE, Dowling SC, et al: Hemoperitoneum caused by rupture of a juvenile granulosa cell tumor in an equine neonate, J Am Vet Med Assoc 193(11):1417, 1988.
291. Harper J, Stewart AJ, Kuhnt L, et al: Ultrasonographic appearance and abdominal haemorrhage associated with a juvenile granulosa cell tumour in a foal, Equine Vet Educ 22(3):115-120, 2010.
292. Boudreaux MK: Inherited platelet disorders, J Vet Emerg Crit Care 22(1):30-41, 2012.
293. Munoz M, Villar I, Garcia-Erce JA: An update on iron physiology, World J Gastroenterol 15(37):4617-4626, 2009.
294. Toribio RE, Bain FT, Mrad DR, et al: Congenital defects in newborn foals of mares treated for equine protozoal myeloencephalitis during pregnancy, J Am Vet Med Assoc 212(5):697-701, 1998.
295. Tallmadge RL, Stokol T, Gould-Earley MJ, et al: Fell pony syndrome: characterization of developmental hematopoiesis failure and associated gene expression profiles, Clin Vaccine Immunol 19(7):1054-1064, 2012.
296. Hintz HF, Hintz RL, Lein DH, et al: Length of gestation periods in thoroughbred mares, J Vet Emerg Crit Care (San Antonio) 3:289-292, 1979.
297. Ropiha RT, Matthews RG, Butterfield RM, et al: The duration of pregnancy in thoroughbred mares, Vet Rec 84(22):552-555, 1969.
298. Sato K, Miyaki M, Sugiyama K, et al: An analytical study of the duration of gestation in horses, Japan J Zootech Sci 44:375-379, 1973.
299. Rossdale PD: Clinical view of disturbances in equine foetal maturation, Equine Vet J Suppl 14:3-7, 1993.
300. Koterba AM: Definitions of equine perinatal disorders: problems and solutions, Equine Vet Educ 5(5):271-273, 1993.
301. Challis JR, Sloboda D, Matthews SG, et al: The fetal placental hypothalamic-pituitary-adrenal (HPA) axis, parturition and post natal health, Mol Cell Endocrinol 185(1-2):135-144, 2001.
302. Silver M, Fowden AL, Knox J, et al: Relationship between circulating tri-iodothyronine and cortisol in the perinatal period in the foal, J Reprod Fertil Suppl 44:619-626, 1991.
303. Leadon DP, Jeffcott LB, Rossdale PD: Behavior and viability of the premature neonatal foal after induced parturition, Am J Vet Res 47(8):1870-1873, 1986.
304. Cross DL, Redmond LM, Strickland JR: Equine fescue toxicosis: signs and solutions, J Anim Sci 73(3):899-908, 1995.
305. Boosinger TR, Brendemuehl JP, Bransby DL, et al: Prolonged gestation, decreased triiodothyronine concentration, and thyroid gland histomor- phologic features in newborn foals of mares grazing acremonion coeno- phialum-infected fescue, Am J Vet Res 56(1):66-69, 1995.
306. Allen AL, Doige CE, Fretz PB, et al: Hyperplasia of the thyroid gland and concurrent musculoskeletal deformities in western Canadian foals: reexamination of a previously described syndrome, Can Vet J 35(1):31-38, 1994.
307. Allen AL, Townsend HG, Doige CE, et al: A case-control study of the congenital hypothyroidism and dysmaturity syndrome of foals, Can Vet J 37(6):349-351, 354, 1996.
308. Ousey JC: Peripartal endocrinology in the mare and foetus, Reprod Domest Anim 39(4):222-231, 2004.
309. Silver M, Ousey JC, Dudan FE, et al: Studies on equine prematurity 2: post natal adrenocortical activity in relation to plasma adrenocorticotrophic hormone and catecholamine levels in term and premature foals, Equine Vet J 16(4):278-286, 1984.
310. Han X, Fowden AL, Silver M, et al: Immunohistochemical localisation of steroidogenic enzymes and phenylethanolamine-N-methyl-transferase (PNMT) in the adrenal gland of the fetal and newborn foal, Equine Vet J 27(2):140-146, 1995.
311. Challis JR, Sloboda DM, Alfaidy N, et al: Prostaglandins and mechanisms of preterm birth, Reproduction 124(1):1-17, 2002.
312. Alfaidy N, Xiong ZG, Myatt L, et al: Prostaglandin f2alpha potentiates cortisol production by stimulating 11beta-hydroxysteroid dehydrogenase 1: a novel feedback loop that may contribute to human labor, J Clin Endocrinol Metab 86(11):5585-5592, 2001.
313. Silver M, Fowden AL: Prepartum adrenocortical maturation in the fetal foal: responses to ACTH, J Endocrinol 142(3):417-425, 1994.
314. Jeffcott LB, Rossdale PD, Leadon DP: Haematological changes in the neonatal period of normal and induced premature foals, J Reprod Fertil Suppl 32:537-544, 1982.
315. Fowden AL, Mundy L, Ousey JC, et al: Tissue glycogen and glucose 6-phosphatase levels in fetal and newborn foals, J Reprod Fertil Suppl 44:537-542, 1991.
316. Nathanielsz PW, Berghorn KA, Derks JB, et al: Life before birth: effects of cortisol on future cardiovascular and metabolic function, Acta Paediatr 92(7):766-772, 2003.
317. Breuhaus BA: Thyroid function and dysfunction in term and premature equine neonates, J Vet Intern Med 28(4):1301-1309, 2014.
318. Irvine CH, Evans MJ: Postnatal changes in total and free thyroxine and triiodothyronine in foal serum, J Reprod Fertil Suppl 23:709-715, 1975.
319. Wallace MJ, Hooper SB, Harding R: Role of the adrenal glands in the maturation of lung liquid secretory mechanisms in fetal sheep, Am J Physiol 270(1 Pt 2):R33-R40, 1996.
320. Matthews SG, Challis JR: Developmental regulation of preproenkephalin mRNA in the ovine paraventricular nucleus: effects of stress and glucocorticoids, Bram Res Dev Brain Res 86(1-2):259-267, 1995.
321. Panzani S, Carluccio A, Probo M, et al: Comparative study on 15-ketodihydro-PGF(2alpha) plasma concentrations in newborn horses, donkeys and calves, Reprod Domest Anim 47(1):82-86, 2012.
322. Allen WR, Wilsher S, Stewart F, et al: The influence of maternal size on placental, fetal and postnatal growth in the horse. II. Endocrinology of pregnancy, J Endocrinol 172(2):237-246, 2002.
323. Maxwell LK, Bentz BG, Bourne DW, et al: Pharmacokinetics of valacyclovir in the adult horse, J Vet Pharmacol Ther 31(4):312-320, 2008.
324. Santschi EM, Slone DE, Gronwall R, et al: Types of colic and frequency of postcolic abortion in pregnant mares: 105 cases (1984-1988), J Am Vet Med Assoc 199(3):374-377, 1991.
325. Ousey JC, Rossdale PD, Dudan FE, et al: The effects of intrafetal ACTH administration on the outcome of pregnancy in the mare, Reprod Fertil Dev 10(4):359-367, 1998.
326. Rossdale PD, McGladdery AJ, Ousey JC, et al: Increase in plasma progestagen concentrations in the mare after foetal injection with CRH, ACTH or betamethasone in late gestation, Equine Vet J 24(5):347-350,
1992.
327. Ousey JC, Rossdalet PD, Palmer L, et al: Effects of maternally administered depot ACTH(1-24) on fetal maturation and the timing of parturition in the mare, Equine Vet J 32(6):489-496, 2000.
328. Ousey JC, Rossdale PD, Fowden AL, et al: Effects of manipulating intrauterine growth on post natal adrenocortical development and other parameters of maturity in neonatal foals, Equine Vet J 36(7):616-621, 2004.
329. Fowden AL, Silver M, Ellis L, et al: Studies on equine prematurity 3: insulin secretion in the foal during the perinatal period, Equine Vet J 16(4):286-291, 1984.
330. Lester GD: Outcomes in foals with a gestational age less than 320 days, in Proceedings of Havemeyer Foundation, Neonatal Septicemia 3:42-44, 2001.
331. Rose RJ, Hodgson DR, Leadon DP, et al: Effect of intranasal oxygen administration on arterial blood gas and acid base parameters in spontaneously delivered, term induced and induced premature foals, Res Vet Sci 34(2):159-162, 1983.
332. Pattle RE, Rossdale PD, Schock C, et al: The development of the lung and its surfactant in the foal and in other species, J Reprod Fertil Suppl 23:651-657, 1975.
333. Joynt C, Cheung PY: Treating hypotension in preterm neonates with vasoactive medications, Front Pediatr 6:86, 2018.
334. Muir WW: The haemodynamic effects of milrinone HCl in halothane anaesthetised horses, Equine Vet J Suppl 19:108-113, 1995.
335. van der Heide-Jalving M, Kamphuis PJ, van der Laan MJ, et al: Short- and long-term effects of neonatal glucocorticoid therapy: is hydrocortisone an alternative to dexamethasone?, Acta Paediatr 92(7):827-835, 2003.
336. Peeples ES: An evaluation of hydrocortisone dosing for neonatal refractory hypotension, J Perinatol 37(8):943-946, 2017.
337. Stewart JH, Rose RJ, Barko AM: Response to oxygen administration in foals: effect of age, duration and method of administration on arterial blood gas values, Equine Vet J 16(4):329-331, 1984.
338. Kutasi O, Horvath A, Harnos A, et al: Radiographic assessment of pulmonary fluid clearance in healthy neonatal foals, Vet Radiol Ultrasound 50(6):584-588, 2009.
339. Schliewert EC, Lascola KM, O’Brien RT, et al: Comparison of radiographic and computed tomographic images of the lungs in healthy neonatal foals, Am J Vet Res 76(1):42-52, 2015.
340. Altmaier K, Morris EA: Dorsal displacement of the soft palate in neonatal foals, Equine Vet J 25(4):329-332, 1993.
341. Shappell KK, Caron JP, Stick JA, et al: Staphylectomy for treatment of dorsal displacement of the soft palate in two foals, J Am Vet Med Assoc 195(10):1395, 1989.
342. Traub-Dargatz JL, Ingram JT, Stashak TS, et al: Respiratory stridor associated with polymyopathy suspected to be hyperkalemic periodic paralysis in four quarter horse foals, J Am Vet Med Assoc 201(1):85-89, 1992.
343. Aleman M, Nieto JE, Benak J, et al: Tracheal collapse in American miniature horses: 13 cases (1985-2007), J Am Vet Med Assoc 233(8):1302-1306,
2008.
344. Patel JR, Heldens J: Equine herpesviruses 1 (EHV-1) and 4 (EHV-4)- epidemiology, disease and immunoprophylaxis: a brief review, Vet J 170(1):14-23, 2005.
345. Patterson-Kane JC, Carrick JB, Axon JE, et al: The pathology of bronchointerstitial pneumonia in young foals associated with the first outbreak of equine influenza in Australia, Equine Vet J 40(3):199-203, 2008.
346. Vaala WE, Hamir AN, Dubovi EJ, et al: Fatal, congenitally acquired infection with equine arteritis virus in a neonatal thoroughbred, Equine Vet J 24(2):155-158, 1992.
347. Begg AP, Reece RL, Hum S, et al: Pathological changes in horses dying with equine influenza in Australia, 2007, Aust Vet J 89(s1):19-22, 2011.
348. Rezabek GB, Donahue JM, Giles RC, et al: Histoplasmosis in horses, J Comp Pathol 109(1):47-55, 1993.
349. Wilkins PA: Lower respiratory problems of the neonate, Vet Clin North Am Equine Pract 19(1):19-33, v, 2003.
350. Marble SL, Edens LM, Shiroma JT, et al: Subcutaneous emphysema in a neonatal foal, J Am Vet Med Assoc 208(1):97-99, 1996.
351. Borchers A, Eps AV, Zedler S, et al: Thoracic trauma and post operative lung injury in a neonatal foal, Equme Vet Educ 21(4):186-191, 2009.
352. Song EK, Mann FA, Wagner-Mann CC: Comparison of different tube materials and use of Chinese finger trap or four friction suture technique for securing gastrostomy, jejunostomy, and thoracostomy tubes in dogs, Vet Surg 37(3):212-221, 2008.
353. Wong DM, Leger LC, Scarratt WK, et al: Uroperitoneum and pleural effusion in an American paint filly, Equine Vet Educ 16(6):290- 293, 2004.
354. Vander Werf KA, Beard LA, McMurphy RM: Urinothorax in a quarter horse filly, Equine Vet Educ 22(5):239-243, 2010.
355. Wilkins PA: Respiratory distress in foals with uroperitoneum: possible mechanisms, Equine Vet Educ 16(6):293-295, 2004.
356. McGillick EV, Lee K, Yamaoka S, et al: Elevated airway liquid volumes at birth: a potential cause of transient tachypnea of the newborn, J Appl Physiol 123(5):1204-1213, 2017.
357. Hoffman AM, Viel L: A percutaneous transtracheal catheter system for improved oxygenation in foals with respiratory distress, Equine Vet J 24(3):239-241, 1992.
358. Palmer JE: Ventilatory support of the critically ill foal, Vet Clin North Am Equine Pract 21(2):457-486, vii, 2005.
359. Costa MC, Stampfli HR, Allen-Vercoe E, et al: Development of the faecal microbiota in foals, Equine Vet J 48(6):681-688, 2016.
360. Selim AM, Abou-Zeid AA: Retrospective study on the cause of bacterial diarrhea in horses in minnesota, Res J Anim Sci 4(2):77-82, 2010.
361. Holland RE, Sriranganathan N, DuPont L: Isolation of enterotoxigenic escherichia coli from a foal with diarrhea, J Am Vet Med Assoc 194(3):389- 391, 1989.
362. Tzipori S, Makin T, Smith M, et al: Enteritis in foals induced by rotavirus and enterotoxigenic escherichia coli, Aust Vet J 58(1):20-23, 1982.
363. East LM, Savage CJ, Traub-Dargatz JL, et al: Enterocolitis associated with clostridium perfringens infection in neonatal foals: 54 cases (19881997), J Am Vet Med Assoc 212(11):1751-1756, 1998.
364. Uzal FA, Diab SS, Blanchard P, et al: Clostridium perfringens type C and clostridium difficile co-infection in foals, Vet Microbiol 156(3):395-402,
2012.
365. Magdesian KG, Leutenegger CM: Real-time PCR and typing of clostridium difficile isolates colonizing mare-foal pairs, Vet J 2010.
366. Magdesian KG: Neonatal foal diarrhea, Vet Clin North Am Equine Pract 21(2):295-312, vi, 2005.
367. Weese JS, Cote NM, deGannes RV: Evaluation of in vitro properties of di-tri-octahedral smectite on clostridial toxins and growth, Equine Vet J 35(7):638-641, 2003.
368. John J, Roediger K, Schroedl W, et al: Development of intestinal microflora and occurrence of diarrhoea in sucking foals: effects of Bacillus cereus var. toyoi supplementation, BMC Vet Res 11(1):34, 2015.
369. Strobel C, Gunther E, Romanowski K, et al: Effects of oral supplementation of probiotic strains of lactobacillus rhamnosus and enterococcus faecium on diarrhoea events of foals in their first weeks of life, J Anim Physiol Anim Nutr (Berl) 2018.
370. Weese JS, Anderson ME, Lowe A, et al: Screening of the equine intestinal microflora for potential probiotic organisms, Equine Vet J 36(4):351-355, 2004.
371. Weese JS, Rousseau J: Evaluation of lactobacillus pentosus WE7 for prevention of diarrhea in neonatal foals, J Am Vet Med Assoc 226(12):2031- 2034, 2005.
372. Sarma PN, Tang YJ, Prindiville TP, et al: Genotyping of bacteroides fragilis isolates from stool specimens by arbitrarily-primed-PCR, Diagn Microbiol Infect Dis 37(4):225-229, 2000.
373. Myers LL, Shoop DS, Byars TD: Diarrhea associated with enterotoxigenic bacteroides fragilis in foals, Am J Vet Res 48(11):1565-1567, 1987.
374. Tzipori S, Hayes J, Sims L, et al: Streptococcus durans: an unexpected enteropathogen of foals, J Infect Dis 150(4):589-593, 1984.
375. Browning GF, Chalmers RM, Snodgrass DR, et al: The prevalence of enteric pathogens in diarrhoeic thoroughbred foals in britain and Ireland, Equine Vet J 23(6):405-409, 1991.
376. Cimprich RE, Rooney JR: Corynebacterium equi enteritis in foals, Vet Pathol 14(2):95-102, 1977.
377. Collins PJ, Cullinane A, Martella V, et al: Molecular characterization of equine rotavirus in Ireland, J Clin Microbiol 46(10):3346-3354, 2008.
378. Conner ME, Darlington RW: Rotavirus infection in foals, Am J Vet Res 41(10):1699-1703, 1980.
379. Zhang M, Zeng CQ, Morris AP, et al: A functional NSP4 enterotoxin peptide secreted from rotavirus-infected cells, J Virol 74(24):11663-11670, 2000.
3 80. Dwyer RM: Rotaviral diarrhea, Vet Clin North Am Equine Pract 9(2):311-319,
1993.
381. Barrandeguy M, Parreno V, Lagos Marmol M, et al: Prevention of rotavirus diarrhoea in foals by parenteral vaccination of the mares: field trial, Dev Biol Stand 92:253-257, 1998.
382. Powell DG, Dwyer Rm, Traub-DargatzJL, et al: Field study of the safety, immunogenicity, and efficacy of an inactivated equine rotavirus vaccine, J Am Vet Med Assoc 211(2):193-198, 1997.
383. Davis E, Rush BR, Cox J, et al: Neonatal enterocolitis associated with coronavirus infection in a foal: a case report, J Vet Diagn Invest 12(2):153-156, 2000.
384. Guy JS, Breslin JJ, Breuhaus B, et al: Characterization of a coronavirus isolated from a diarrheic foal, J Clin Microbiol 38(12):4523-4526, 2000.
385. Slovis N, Elam J, Estrada M, et al: Comprehensive analysis of infectious agents associated with diarrhea in foals in central kentucky, Proc Am Assoc Equine Pract 56:262-266, 2010.
386. Lyons ET, Drudge JH, Tolliver SC: On the life cycle of strongyloides westeri in the equine, J Parasitol 780-787, 1973.
387. Grinberg A, Pomroy WE, Carslak HB, et al: A study of neonatal cryp- tosporidosis of foals in New Zealand, N Z Vet J 57(5):284-289, 2009.
388. Cole DJ, Cohen ND, Snowden K, et al: Prevalence of and risk factors for fecal shedding of cryptosporidium parvum oocysts in horses, J Am Vet Med Assoc 213(9):1296-1302, 1998.
389. Xiao L, Herd RP: Epidemiology of equine cryptosporidium and giardia infections, Equine Vet J 26(1):14-17, 1994.
390. Galuppi R, Piva S, Castagnetti C, et al: Cryptosporidium parvum: from foal to veterinary students, Vet Parasitol 219:53-56, 2016.
391. Kohn CW, Knight DA, Yvorchyk-St Jean KE, et al: A preliminary study of the tolerance of healthy foals to a low residue enteral feeding solution, Equine Vet J 23(5):374-379, 1991.
392. Martens RJ, Malone PS, Brust DM: Oral lactose tolerance test in foals: technique and normal values, Am J Vet Res 46(10):2163-2165, 1985.
393. Santschi EM, Slone DE, Embertson RM, et al: Colic surgery in 206 juvenile thoroughbreds: survival and racing results, Equine Vet J 32(S32):32-36, 2000.
394. Divers TJ, Byars TD, Spirito M: Correction of bilateral ureteral defects in a foal, J Am Vet Med Assoc 192(3):384-386, 1988.
395. Kablack KA, Embertson RM, Bernard WV, et al: Uroperitoneum in the hospitalised equine neonate: retrospective study of 31 cases, 1988-1997, Equine Vet J 32(6):505-508, 2000.
396. Kabura L, Ilibagiza D, Menten J, et al: Intrathecal vs. intramuscular administration of human antitetanus immunoglobulin or equine tetanus antitoxin in the treatment of tetanus: a meta-analysis, Trop Med Int Health 11(7):1075-1081, 2006.
397. Cudd TA, Pauly TH: Necrotizing enterocolitis in two equine neonates, Compend Contin Educ Pract Vet 9:1987.
398. Mariella J, Iacono E, Lanci A, et al: Macroscopic characteristics of the umbilical cord in standardbred, Thoroughbred and warmblood horses, Theriogenology 113:166-170, 2018.
399. Whitwell KE, Jeffcott LB: Morphological studies on the fetal membranes of the normal singleton foal at term, Res Vet Sci 19(1):44-55, 1975.
400. Adams SB, Fessler JF: Umbilical cord remnant infections in foals: 16 cases (1975-1985), J Am Vet Med Assoc 190(3):316, 1987.
401. Bucki EP, Giguere S, Macpherson M, et al: Pharmacokinetics of once-daily amikacin in healthy foals and therapeutic drug monitoring in hospitalized equine neonates, J Vet Intern Med 18(5):728-733, 2004.
402. Magdesian KG, Wilson WD, Mihalyi J: Pharmacokinetics of a high dose of amikacin administered at extended intervals to neonatal foals, Am J Vet Res 65(4):473-479, 2004.
403. Burton AJ, Giguere S, Warner L, et al: Effect of age on the pharmacokinetics of a single daily dose of gentamicin sulfate in healthy foals, Equine Vet J 2012.
404. Gardner SY, Sweeney RW, Divers TJ: Pharmacokinetics of cefotaxime in neonatal pony foals, Am J Vet Res 54(4):576-579, 1993.
405. Meyer S, Giguere S, Rodriguez R, et al: Pharmacokinetics of intravenous ceftiofur sodium and concentration in body fluids of foals, J Vet Pharmacol Ther 32(4):309-316, 2009.
406. Hall TL, Tell LA, Wetzlich SE, et al: Pharmacokinetics of ceftiofur sodium and ceftiofur crystalline free acid in neonatal foals, J Vet Pharmacol Ther 34(4):403-409, 2011.